Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2

Satoshi Akamine, Noriaki Sagata, Yasunari Sakai, Takahiro A. Kato, Takeshi Nakahara, Yuki Matsushita, Osamu Togao, Akio Hiwatashi, Masafumi Sanefuji, Yoshito Ishizaki, Hiroyuki Torisu, Hirotomo Saitsu, Naomichi Matsumoto, Toshiro Hara, Akira Sawa, Shinichi Kano, Masutaka Furue, Shigenobu Kanba, Chad A. Shaw, Shouichi Ohga

Research output: Contribution to journalArticle

Abstract

Advance in the exome-wide sequencing analysis contributes to identifying hundreds of genes that are associated with early-onset epileptic encephalopathy and neurodevelopmental disorders. On the basis of massive sequencing data, functional interactions among different genes are suggested to explain the common molecular pathway underlying the pathogenic process of these disorders. However, the relevance of such interactions with the phenotypic severity or variety in an affected individual remains elusive. In this report, we present a 45-year-old woman with neurofibromatosis type 1 (NF1), infantile-onset epileptic encephalopathy, and severe developmental delay. Whole-exome sequencing identified de novo pathogenic mutations in NF1 and the Schaaf-Yang syndrome-associated gene, MAGEL2. Literature-curated interaction data predicted that NF1 and MAGEL2 proteins were closely connected in this network via their common interacting proteins. Direct conversion of fibroblasts into neurons in vitro showed that neuronal cells from 9 patients with NF1 expressed significantly lower levels of MAGEL2 (54%, p = 0.0047) than those from healthy individuals. These data provide the first evidence that pathogenic mutations of NF1 deregulate the expression of other neurodevelopmental disease-associated genes. De novo mutations in multiple genes may lead to severe developmental phenotypes through their cumulative effects or synergistic interactions.

Original languageEnglish (US)
Pages (from-to)81-85
Number of pages5
JournalEpilepsia Open
Volume3
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Neurofibromatosis 1
Brain Diseases
Mutation
Exome
Genes
Neurofibromin 1
Fibroblasts
Phenotype
Neurons
Proteins

Keywords

  • De novo mutation
  • Direct conversion
  • Early-onset epileptic encephalopathy
  • Functional interaction
  • MAGEL2
  • Neurofibromatosis type 1
  • Whole-exome sequencing

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2. / Akamine, Satoshi; Sagata, Noriaki; Sakai, Yasunari; Kato, Takahiro A.; Nakahara, Takeshi; Matsushita, Yuki; Togao, Osamu; Hiwatashi, Akio; Sanefuji, Masafumi; Ishizaki, Yoshito; Torisu, Hiroyuki; Saitsu, Hirotomo; Matsumoto, Naomichi; Hara, Toshiro; Sawa, Akira; Kano, Shinichi; Furue, Masutaka; Kanba, Shigenobu; Shaw, Chad A.; Ohga, Shouichi.

In: Epilepsia Open, Vol. 3, No. 1, 01.01.2018, p. 81-85.

Research output: Contribution to journalArticle

Akamine, S, Sagata, N, Sakai, Y, Kato, TA, Nakahara, T, Matsushita, Y, Togao, O, Hiwatashi, A, Sanefuji, M, Ishizaki, Y, Torisu, H, Saitsu, H, Matsumoto, N, Hara, T, Sawa, A, Kano, S, Furue, M, Kanba, S, Shaw, CA & Ohga, S 2018, 'Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2', Epilepsia Open, vol. 3, no. 1, pp. 81-85. https://doi.org/10.1002/epi4.12085
Akamine, Satoshi ; Sagata, Noriaki ; Sakai, Yasunari ; Kato, Takahiro A. ; Nakahara, Takeshi ; Matsushita, Yuki ; Togao, Osamu ; Hiwatashi, Akio ; Sanefuji, Masafumi ; Ishizaki, Yoshito ; Torisu, Hiroyuki ; Saitsu, Hirotomo ; Matsumoto, Naomichi ; Hara, Toshiro ; Sawa, Akira ; Kano, Shinichi ; Furue, Masutaka ; Kanba, Shigenobu ; Shaw, Chad A. ; Ohga, Shouichi. / Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2. In: Epilepsia Open. 2018 ; Vol. 3, No. 1. pp. 81-85.
@article{965f57561b9d4f18abde71a4b6656c54,
title = "Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2",
abstract = "Advance in the exome-wide sequencing analysis contributes to identifying hundreds of genes that are associated with early-onset epileptic encephalopathy and neurodevelopmental disorders. On the basis of massive sequencing data, functional interactions among different genes are suggested to explain the common molecular pathway underlying the pathogenic process of these disorders. However, the relevance of such interactions with the phenotypic severity or variety in an affected individual remains elusive. In this report, we present a 45-year-old woman with neurofibromatosis type 1 (NF1), infantile-onset epileptic encephalopathy, and severe developmental delay. Whole-exome sequencing identified de novo pathogenic mutations in NF1 and the Schaaf-Yang syndrome-associated gene, MAGEL2. Literature-curated interaction data predicted that NF1 and MAGEL2 proteins were closely connected in this network via their common interacting proteins. Direct conversion of fibroblasts into neurons in vitro showed that neuronal cells from 9 patients with NF1 expressed significantly lower levels of MAGEL2 (54{\%}, p = 0.0047) than those from healthy individuals. These data provide the first evidence that pathogenic mutations of NF1 deregulate the expression of other neurodevelopmental disease-associated genes. De novo mutations in multiple genes may lead to severe developmental phenotypes through their cumulative effects or synergistic interactions.",
keywords = "De novo mutation, Direct conversion, Early-onset epileptic encephalopathy, Functional interaction, MAGEL2, Neurofibromatosis type 1, Whole-exome sequencing",
author = "Satoshi Akamine and Noriaki Sagata and Yasunari Sakai and Kato, {Takahiro A.} and Takeshi Nakahara and Yuki Matsushita and Osamu Togao and Akio Hiwatashi and Masafumi Sanefuji and Yoshito Ishizaki and Hiroyuki Torisu and Hirotomo Saitsu and Naomichi Matsumoto and Toshiro Hara and Akira Sawa and Shinichi Kano and Masutaka Furue and Shigenobu Kanba and Shaw, {Chad A.} and Shouichi Ohga",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/epi4.12085",
language = "English (US)",
volume = "3",
pages = "81--85",
journal = "Epilepsia Open",
issn = "2470-9239",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2

AU - Akamine, Satoshi

AU - Sagata, Noriaki

AU - Sakai, Yasunari

AU - Kato, Takahiro A.

AU - Nakahara, Takeshi

AU - Matsushita, Yuki

AU - Togao, Osamu

AU - Hiwatashi, Akio

AU - Sanefuji, Masafumi

AU - Ishizaki, Yoshito

AU - Torisu, Hiroyuki

AU - Saitsu, Hirotomo

AU - Matsumoto, Naomichi

AU - Hara, Toshiro

AU - Sawa, Akira

AU - Kano, Shinichi

AU - Furue, Masutaka

AU - Kanba, Shigenobu

AU - Shaw, Chad A.

AU - Ohga, Shouichi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Advance in the exome-wide sequencing analysis contributes to identifying hundreds of genes that are associated with early-onset epileptic encephalopathy and neurodevelopmental disorders. On the basis of massive sequencing data, functional interactions among different genes are suggested to explain the common molecular pathway underlying the pathogenic process of these disorders. However, the relevance of such interactions with the phenotypic severity or variety in an affected individual remains elusive. In this report, we present a 45-year-old woman with neurofibromatosis type 1 (NF1), infantile-onset epileptic encephalopathy, and severe developmental delay. Whole-exome sequencing identified de novo pathogenic mutations in NF1 and the Schaaf-Yang syndrome-associated gene, MAGEL2. Literature-curated interaction data predicted that NF1 and MAGEL2 proteins were closely connected in this network via their common interacting proteins. Direct conversion of fibroblasts into neurons in vitro showed that neuronal cells from 9 patients with NF1 expressed significantly lower levels of MAGEL2 (54%, p = 0.0047) than those from healthy individuals. These data provide the first evidence that pathogenic mutations of NF1 deregulate the expression of other neurodevelopmental disease-associated genes. De novo mutations in multiple genes may lead to severe developmental phenotypes through their cumulative effects or synergistic interactions.

AB - Advance in the exome-wide sequencing analysis contributes to identifying hundreds of genes that are associated with early-onset epileptic encephalopathy and neurodevelopmental disorders. On the basis of massive sequencing data, functional interactions among different genes are suggested to explain the common molecular pathway underlying the pathogenic process of these disorders. However, the relevance of such interactions with the phenotypic severity or variety in an affected individual remains elusive. In this report, we present a 45-year-old woman with neurofibromatosis type 1 (NF1), infantile-onset epileptic encephalopathy, and severe developmental delay. Whole-exome sequencing identified de novo pathogenic mutations in NF1 and the Schaaf-Yang syndrome-associated gene, MAGEL2. Literature-curated interaction data predicted that NF1 and MAGEL2 proteins were closely connected in this network via their common interacting proteins. Direct conversion of fibroblasts into neurons in vitro showed that neuronal cells from 9 patients with NF1 expressed significantly lower levels of MAGEL2 (54%, p = 0.0047) than those from healthy individuals. These data provide the first evidence that pathogenic mutations of NF1 deregulate the expression of other neurodevelopmental disease-associated genes. De novo mutations in multiple genes may lead to severe developmental phenotypes through their cumulative effects or synergistic interactions.

KW - De novo mutation

KW - Direct conversion

KW - Early-onset epileptic encephalopathy

KW - Functional interaction

KW - MAGEL2

KW - Neurofibromatosis type 1

KW - Whole-exome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85063925160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063925160&partnerID=8YFLogxK

U2 - 10.1002/epi4.12085

DO - 10.1002/epi4.12085

M3 - Article

C2 - 29588991

AN - SCOPUS:85063925160

VL - 3

SP - 81

EP - 85

JO - Epilepsia Open

JF - Epilepsia Open

SN - 2470-9239

IS - 1

ER -